NCIC

Join @SaferCareVic for a clinical conversation on assessing penicillin allergies, identifying low-risk cases, and understanding the testing process. Tuesday, 5 May 2026 1:00 PM Online Presenters: Belinda Lambros & Rebecca Hall Register🔗@c0e0601f-0fac-449c-9c88-a104c4eb9f28" target="_blank" rel="nofollow noopener">events.teams.microsoft.com/event/aeb351e8…

Couldn’t join us for our guideline showcase? Each chapter of the Australasian Consensus Guidelines for the Management of Neutropenic Fever in Patients with Cancer | 2024 was presented by the corresponding author. You can now watch the full recording: cancerandinfections.org/febrile-neutro…

You are invited to attend a series of presentations on the Australasian Neutropenic Fever Guidelines 2024, delivered chapter by chapter by the guideline authors! Join: teams.microsoft.com/meet/441992508…

We thank Dr. Rebekah Lane for visiting the NCIC as a two-week visiting fellow from Auckland City Hospital. We wish her all the best and look forward to welcoming her again, continuing to strengthen our collaboration with our colleagues in New Zealand!

This week, Prof. Monica Slavin & Dr. Abby Douglas were invited guests at #Tandem26 (@ASTCT & @CIBMTR ) in Salt Lake City. Monica presented Challenging Cases in Transplant & Abby debated- Is Advanced Imaging in ID Worth the Cost? (“Con”).

50+ experts from Aus and NZ - incl. 20 from @PeterMacCC and @NCICancer - have delivered new guidelines for neutropenic fever in cancer care. A multitdosciplinary collab that's shaping safer, more effective cancer care across the region. Read more 👉 onlinelibrary.wiley.com/toc/14455994/2…

Recently published- updated Australasian guidelines for neutropenic fever in cancer patients! ✅ Includes paediatric recommendations for the first time ✅ Covers NZ ✅ New chapters on modern therapies, ambulatory care & patient engagement Read here: onlinelibrary.wiley.com/toc/14455994/2…

Recently, @michyong2 presented at the 9th Annual #ICBMT2025 in Busan, Korea on CMV Infection in Allogeneic HSCT: Risk Stratification and Prevention, focused on advances in prophylaxis for CMV management after allogeneic hematopoietic stem cell transplantation- Congratulations!

@martinhoenigl @TIMM_cc @eurconfmedmycol Great meeting and really fantastic to see lots of NCIC works mentioned by current and future collaborators. @c_garciavidal @FannyLanternier @michyong2 @monicaslavin

#TIMM2025 @TIMM_cc @eurconfmedmycol What a conference so far... Fantastic science, location and so many friends from all around the world here to meet, chat and plan fungal.

Australia’s first multi-site study of infections in cancer & transplant patients, PROSPER, is now published in BMJ Open! It will guide future infection prevention & control for this vulnerable group. Read the full article here: bmjopen.bmj.com/content/15/7/e…

🔥🔥Just published in #CID world-first clinical trial of IFN-a nasal spray vs placebo reduced #COVID 🦠 incidence 📉 by 40% in cancer pts. Well tolerated, safe, effective… Full link here: #google_vignette" target="_blank" rel="nofollow noopener">academic.oup.com/cid/advance-ar…

You're invited to the NCIC Showcase! Learn about our work in infection & cancer care through rapid 2-min talks from clinicians, scientists & more. 📅 7 Aug | 🕧 12:30–2PM | 🏢 PMCC & Teams 🍽️ Lunch/tea included 🔗 Register: cancerandinfections.org/ncic-showcase

Join us for the Asia Fungal Working Group and @ASIDANZ 's ANZMIG Fungal Frontier Asia Pacific webinar on Emerging Dermatophyte Infections: Arrival of Antifungal Drug Resistance. Date: 3rd of September Time: 19.30 AEST Location: Online Register here: asidevents.eventsair.com/anzmig-2025-we…

📰 July Newsletter is Out Now! Catch up on the latest updates, research highlights, and upcoming events. 📖 Read it here: cancerandinfections.org/newsletter

2 WEEKS AWAY Join us Friday July 25 in Melbourne (or online!) for updates on Candida & other yeasts in clinical & lab diagnosis + deep dive into the Australasian Candidemia Study III. Register: cancerandinfections.org/acsiii-regis...

We were proud to be well represented at the inaugural The @TSANZ_txsoc Infectious Disease Day on 20 June 2025 — a fantastic event co-badged with @ASIDANZ Immunocompromised Host Special Interest Group.

Read the article: sciencedirect.com/science/articl…

Prof Monica Slavin - “Very pleased to be part of this important study of olorofim, a novel antifungal drug for difficult-to-treat fungal infections. It was active against infections resistant to or failing existing treatments and offers a much-needed option for our patients.”

Today, Belinda Lambros, Clinical Nurse Practitioner and Research Fellow, presented on the Nursing Considerations from the Australasian Consensus Guidelines for Neutropenic Fever 2024 update at the 2025 @CNSA_ORG and @ISNCC congress.